Home > Research Team > Judith Balmaña
Current positions
- Head of the High Risk and Cancer Prevention Group
- Specialist in Medical Oncology at the Vall d’Hebron University Hospital
- Certificate of the ECFMG (Educational Commission for Foreign Medical Graduates), 1999
- Member of the Spanish Society of Medical Oncology (SEOM)
- Member of InSiGHT (International Society for Gastrointestinal Hereditary Tumors)
- Member of the board of the SEOM Hereditary Cancer Section
- Coordinator of the family cancer module of the 1st Master’s Degree in Genetic Counselling at Pompeu Fabra University (UPF). Member of ESMO
Academic Qualifications
- Degree in Medicine and Surgery from the University of Barcelona, 1995
- Doctorate in Medicine from the Universitat Autònoma de Barcelona, 2009
Prizes and Scholarships
- Scholarship to study at the Risk and Prevention Clinic at Dana Farber Cancer Institute, Boston, Mass. USA.
- Participant in the exchange program organized by the International Federation of Medical Students Association.
Most relevant scientific publications
- Fortuny D, Balmaña J, Graña B, Torres A, Ramón Y Cajal T, Darder E, Gadea N, Velasco A, López C, Sanz J, Alonso C, Brunet J. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Hum. Reprod. 2009 Apr; 24(4): 1000-6
- Balmaña J, Balaguer F, Castellví-Bel S, Steyerberg EW, Andreu M, Llor X, Jover R, Castells A, Syngal S. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J. Med. Genet. 2008 Sep; 45(9): 557-63
- Balmaña J, Stockwell DH, Steyerberg EW, Stoffel EM, Deffenbaugh AM, Reid JE, Ward B, Scholl T, Hendrickson B, Tazelaar J, Burbidge LA, Syngal S. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006 Sep; 296(12): 1469-78
